FIELD: medicine.
SUBSTANCE: invention relates to hepatic fibrosis inhibitor containing pyrazolopyrimidinon derivative of the following formula (1) as active ingredient, pharmaceutical composition for liver cirrhosis treatment and prevention, portal hypertension inhibitor comprising pyrazolopyrimidinon formula derivative (1), pharmaceutical composition as prevention care for treatment of complications caused by portal hypertension and containing pyrazolopyrimidinon formula (1) derivative as active ingredient.
EFFECT: improved medical compliance in patients suffering from liver diseases.
5 cl
Authors
Dates
2009-10-10—Published
2005-10-21—Filed